Infertility Therapy for Women Age Thirty-eight and Older

Status unconfirmed · Not applicable

Conditions studied: Infertility

In brief

This study will determine the most effective treatment strategy for infertile couples who present when the female partner is 38 years to the 43rd birthday and the couples are determined to have a reasonable chance for success.

Key facts

Study ID

NCT00246506

Run by

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

People needed

450

Starts

2003-07-01

Expected to finish

2013-04-01

Last updated by the study team

2013-01-15

Who can join

Age: 38 and older, up to 43. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Female partner age from 38th to the 43rd birthday at the time of recruitment and six months of infertility.
• Male partner has a normal semen analysis showing at least 15 million total motile sperm/ejaculate and at least 1% normal forms by strict criteria, or at least 5 million total motile sperm in an IUI prep.
• Patients must have at least one ovary and at least one ipsilateral patent fallopian tube confirmed by HSG or laparoscopy. Pelvic pathology may be present but must be amenable to operative laparoscopy with the pelvis restored to a functional state, including surgically corrected stages I and II endometriosis. Patients with stage III endometriosis qualify only if the disease is limited to an isolated endometrioma in one or both ovaries and once removed the pelvis is restored to a functional state. For patients with a single patent fallopian tube, the open tube cannot have had a previous ectopic (tubal) pregnancy, and the closed tube cannot be a hydrosalpinx (a tube that is blocked at the end and filled with fluid), unless a cauterization has been performed at the junction of the uterus and fallopian tube. Alternatively, that tube could be removed.
• 4. Normal uterine cavity demonstrated by HSG, sonohysterogram (SHG), or hysteroscopy; pathology of the uterine cavity amenable to operative hysteroscopy (cavity restored to normal and demonstrated by postoperative study).
• Regular menstrual cycles ranging from 21 - 45 days (patients with occasional cycles, i.e. 1 -2 /year, outside this range will be acceptable).
• Acceptable ovarian reserve demonstrated in all patients by a clomiphene challenge test, i.e., cycle day 3 FSH/E2 values of <15 mIU/mL and <100 pg/mL, respectively, and cycle day 10 FSH < 15 mIU/ml. (Note: normal ovarian reserve is represented by FSH values less than 10-12 mIU/mL; our acceptable values represent the transition zone.) Normal TSH and prolactin levels.
• Informed consent from both partners.
• Female body mass index ≤ 38.

You may not qualify if…

• Previous tubal or uterine cavity reconstructive surgery in which the pelvis or uterine cavity was not restored to functional.
• Unilateral or bilateral hydrosalpinx (a tube that is blocked at the end and filled with fluid) that has not had a cauterization performed at the junction of the uterus and fallopian tubes, or previous removal of a fallopian tube or an ovary.
• A laparoscopy that demonstrated pelvic adhesions or stage I or II endometriosis for which the pelvis could not be restored to normal by surgery, or endometriosis that was not ablated or excised. All patients with stage IV endometriosis, and those with stage III unless the disease is limited to an isolated endometrioma in one or both ovaries and once removed the pelvis is restored to a functional state.
• One or more prior ectopic pregnancies in which both affected tubes were rendered nonfunctional. One ectopic pregnancy if it existed in the single remaining tube. Two or more ectopic pregnancies even if both tubes are patent.
• Severe male factor (i.e. semen analysis not meeting criteria listed above). Couples using donor semen will be excluded
• Previous treatment with IUI or IVF or for normal ovulatory patients with gonadotropins.
• Inadequate ovarian reserve demonstrating FSH 15 mIU/mL or higher on cycle days 3 or 10 or estradiol 100 pg/mL or higher on cycle day 3.
• Anovulatory patients or those whose cycles are routinely < 21 days or > 45 days in length.
• Patients requiring gamete intrafallopian tube transfer (GIFT), zygote intrafallopian tube transfer (ZIFT), or tubal embryo transfer (TET).
• BMI greater than 38.

Where it is running

• Brigham and Women's Hospital — Boston, Massachusetts, United States
• Boston IVF — Brookline, Massachusetts, United States
• Boston IVF — Quincy, Massachusetts, United States
• Boston IVF — Waltham, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.